Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer — Stella

Home/Anatomic Stage I Breast Cancer AJCC v8/

View on ClinicalTrials.gov

Recruiting

Back to Anatomic Stage I Breast Cancer AJCC v8 trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington

Key details

Phase

Post-approval study

Sponsor

University of Washington

Collaborators

National Cancer Institute (NCI)

Enrollment target

~68 participants

Started

January 2022

Primary completion

June 2026

Age range

18 Years and older

Sex

Female only

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.